All Updates

All Updates

icon
Filter
M&A
Altaris acquires Sharecare for USD 518 million to expand offerings
Preventive Healthcare
Jun 21, 2024
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Yesterday
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Preventive Healthcare

Preventive Healthcare

Jun 21, 2024

Altaris acquires Sharecare for USD 518 million to expand offerings

M&A

  • Digital therapeutics (DTx) provider Sharecare is to be acquired by healthcare investment firm Altaris for a consideration of USD 518 million at a sale price of USD 1.43 per share. The sale price is at a premium of ~85% to Sharecare’s closing price on June 20, 2024.

  • Post-acquisition, Sharecare will transition from a publicly traded company to a privately owned entity. Through the acquisition, Sharecare aims to leverage Altaris' healthcare expertise, increased capital, and operational flexibility to enhance solutions across Sharecare's three business channels.

  • Analyst QuickTake: M&A in the DTx space has been active for the past year. DTx company Sidekick Health acquired PINK! in June 2024 and aidhere in October 2023 to expand its offerings. Additionally, Click Therapeutics acquired Better Therapeutics' DTx assets in May 2024 , while Mahana Therapeutics expanded its DTx in the European market by acquiring HiDoc Technologies (Cara Care) in March 2024 .

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.